443 top medical experts on Mastocytosis across 40 countries and 33 U.S. states, including 302 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Mastocytosis: A rare neoplastic disorder characterized by a clonal proliferation of mast cells, associated with KIT-D816 mutations, and accompanied by aberrant mast cell activation. The abnormal increase of mast cells may occur in only the skin (mastocytosis, cutaneous), in extracutaneous tissues involving multiple organs (mastocytosis, systemic), or in solid tumors (mastocytoma).
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Connective Tissue Neoplasms (1,412), Mast Cell Activation Disorders (23) and Narrower Categories: Cutaneous Mastocytosis (1,069), Mast-Cell Sarcoma (402), Mastocytoma (686), Systemic Mastocytosis (2,360).
  4. Clinical Trials ClinicalTrials.gov : at least 70 including 6 Active, 35 Completed, 16 Recruiting


  

        

                    


    Computing Expert Listing ...

);